Weill Cornell Medical College
New Feil Family Brain and Mind Research Institute Established at Weill Cornell
Weill Cornell Medical College has established the new Feil Family Brain and Mind Research Institute, a unique, multidisciplinary translational neuroscience research hub. Named in honor of long-time benefactors Gertrude and Louis Feil, the institute was created with a generous $28 million gift from the Feil Family.
Dr. Costantino Iadecola, a leading neuroscientist in the field of cerebrovascular diseases, stroke and dementia, will direct the Feil Family Brain and Mind Research Institute. Dr. Iadecola also serves as the Anne Parrish Titzell Professor of Neurology at Weill Cornell and as a neurologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Designed to rapidly accelerate the translation of breakthrough research discoveries from the laboratory to the neurological patient’s bedside, the institute’s goal is to develop the most advanced personalized therapeutic solutions for patients with devastating brain diseases, such as Alzheimer’s disease, Parkinson’s disease, stroke and multiple sclerosis. | Full Text
previous entriesAbout Us
Weill Cornell Medical College, Cornell University’s medical school, located in New York City, is renowned for its excellence in teaching, research, and patient care locally, nationally, and globally. Physicians and scientists of the Medical College are engaged in cutting-edge research from lab bench-to-bedside, aimed at unlocking mysteries of the human body in health and sickness and developing new treatments and prevention strategies.
Our Priorities
The $1.3 billion Discoveries that Make a Difference Campaign, which began in 2006, supports groundbreaking research initiatives in medical research.
Discoveries builds on Weill Cornell's previous campaigns — which focused on basic science, education and patient care — by investing in translational “bench-to-bedside” research to rapidly convert laboratory findings into new treatments and therapies for patients. The cornerstone of the Campaign is the new Medical Research Building on East 69th Street between York and First Avenue.
Strategic Vision
The Discoveries that Make a Difference Campaign is the third phase of Weill Cornell’s strategic plan, and is designed to build on the successes of the earlier phases by uniting basic, translational, and clinical research into an integrated biomedical research enterprise.
Weill Cornell Events
May 22nd
Neurology Grand Rounds Lecture
May 23rd
Coding Immunizations Workshop
May 29th
Incident to Rules Workshop
May 31st
Cosmetic Dermatology Conference
News From Weill Cornell
The Research Leads to Cures Initiative
The Research Leads to Cures Initiative, the most recent phase in Weill Cornell’s Discoveries that Make a Difference Campaign, focuses on supporting the scientists and priority research programs that spearhead the medical research leading to tomorrow’s cures.
Transforming the Research Landscape
The cornerstone of the Discoveries Campaign is the new Medical Research Building (MRB) now rising on East 69th Street between York and First Avenues. This 480,000 square-foot facility will include 16 programmable floors and become the hub for Weill Cornell’s significantly expanded bench-to-bedside translational research initiatives.
Breakthroughs
Researchers at Weill Cornell are leaders in medical breakthroughs that will transform the quality of medical care and assure longer, healthier lives for us, our children, grandchildren, and future generations. Their brain power, meticulous quest for answers, and relentless passion—all are the heart of the Research Leads to Cures initiative. Learn more about Weill Cornell’s most recent research that is leading to cures.
Contacts
| Development |
|
Public Affairs |
|
Lucille Ferraro |
|
John Rodgers |